Key result
Improvement of metabolic control in type 2 diabetic patients did not change plasma NOX levels (13.5 vs 14.3 micromol/L) but decreased the urinary excretion fraction of NOX (1.88% vs 3.22%, P=0.031).
Why the study?
Does improved metabolic control affect plasma levels and urinary excretion of nitrates and nitrites in type 2 diabetic patients?
Observational (n=20)
Does improved metabolic control affect plasma levels and urinary excretion of nitrates and nitrites in type 2 diabetic patients?
Absolute Event Rate: 13.5% vs 14.3%
In type 2 diabetic patients, improved metabolic control does not change plasma NOX levels but decreases the urinary excretion fraction of NOX, suggesting hyperglycemia affects renal handling rather than systemic NO production.
May indicate selective renal NOX effects with glycemic control in T2DM; leaves open implications for complications and needs prospective confirmation.
The measurement of nitrite and nitrate levels in plasma and urine is an approach to assess the activity of the endogenous nitric oxide (NO) system. The aim of the present study was to evaluate whether metabolic control may affect plasma levels and urinary excretion of nitrates and nitrites in type 2 diabetic patients. 2. Twenty consecutive type 2 diabetic patients were studied twice: first (study 1), under poor metabolic control; and, second, after improved metabolic conditions. Determinations of the main metabolic parameters and of plasma nitrates and nitrites (NOX) were performed in the fasting state. A 24 h urinary specimen was obtained for glycosuria, NOX and creatinine. Diet compliance and home blood glucose monitoring was evaluated on a weekly basis until study 2 was performed after 32 +/- 7 days: then, an identical protocol was repeated (study 2). 3. Fasting plasma glucose was lower in study 2 (8.27 +/- 2.11 vs 10.77 +/- 3.88 mmol/L, respectively; P < 0.05); similarly glycosylated haemoglobin (HbA1c) improved significantly. Plasma NOX levels were similar between the first and second studies (14.3 +/- 7.8 vs 13.5 +/- 8.1 micromol/L, respectively); nor were any differences observed in urinary NOX excretion rates (726 +/- 607 vs 689 +/- 444 micromol/day, respectively). The urinary excretion fraction of NOX was higher during study 1 than during study 2 (3.22 +/- 2.38 vs 1.88 +/- 1.98%, respectively; P = 0.031). A relationship was observed between fasting plasma glucose levels and the urinary excretion fraction of NOX (r2 = 0.12; P = 0.026). 4. In type 2 diabetic patients, plasma and urinary levels of NOX do not change after improvement of metabolic control. A worse metabolic control is associated with an increased urinary fraction excretion of NOX: thus, changes in plasma NOX concentration may reflect the effect of hyperglycaemia in the renal handling of these compounds rather than the effects on the L-arginine-NO pathway.
No takes yet. Share an insight, caveat, or question.
Francesconi et al. (2001) conducted an observational in Type 2 diabetes (n=20). Improved metabolic control vs. Poor metabolic control was evaluated on Plasma nitrates and nitrites (NOX) levels (micromol/L). Improvement of metabolic control in type 2 diabetic patients did not change plasma NOX levels (13.5 vs 14.3 micromol/L) but decreased the urinary excretion fraction of NOX (1.88% vs 3.22%, P=0.031).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: